Back to company

SPECIALLÆGESELSKABET ØRE-NÆSE-HALSKLINIKKEN MORTEN ROSENKILDE QVIST ApS: Financial statements 2014

CVR: 32155014

SPECIALLÆGESELSKABET ØRE-NÆSE-HALSKLINIKKEN MORTEN ROSENKILDE QVIST ApS (CVR 32155014) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 4,409,465 and a net result of DKK 132,519 compared with DKK 38,392 the year before. That is an increase of 23.4% compared with the year before. The profit margin was 3%. Equity amounted to DKK 306,287. The solvency ratio was 13.3%.

Revenue
4,409,465 kr.
Gross Profit
3,787,083 kr.
Profit/Loss
132,519 kr.
Equity
306,287 kr.
Total Assets
2,297,844 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20144.4 mio.3.8 mio.133 t.306 t.-
20133.6 mio.3 mio.38 t.270 t.-
20123.9 mio.3.3 mio.129 t.327 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on SPECIALLÆGESELSKABET ØRE-NÆSE-HALSKLINIKKEN MORTEN ROSENKILDE QVIST ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2014

SPECIALLÆGESELSKABET ØRE-NÆSE-HALSKLINIKKEN MORTEN ROSENKILDE QVIST ApS: The 2013 annual report is outApr 12, 2014

SPECIALLÆGESELSKABET ØRE-NÆSE-HALSKLINIKKEN MORTEN ROSENKILDE QVIST ApS has published its annual report for 2013. Revenue came to DKK 3,573,059, and the net result was DKK 38,392.

About SPECIALLÆGESELSKABET ØRE-NÆSE-HALSKLINIKKEN MORTEN ROSENKILDE QVIST ApS

SPECIALLÆGESELSKABET ØRE-NÆSE-HALSKLINIKKEN MORTEN ROSENKILDE QVIST ApS is a Danish company of the type Anpartsselskab based in Svendborg, founded in 2009. The company is registered under the industry Speciallægers aktiviteter. The management consists of Morten Rosenkilde Qvist. The company is owned by Morten Rosenkilde Qvist. The company has 4 employees. In 2025, the company reported revenue of DKK 4,463,480 and a net result of DKK 270,698 compared with DKK 117,182 the year before. Equity amounted to DKK 434,417.